Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic

Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic have?

Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic has 2,920 citations in the OpenAlex counts ScholarIQ stores.

When was Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic published?

Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic has 2018 year in the ScholarIQ index.

What is the open-access status of Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic?

Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic has bronze oa status in the ScholarIQ index.

What is the DOI of Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic?

The DOI for Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic is on the source record.

What is the PMID of Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic?

The PMID for Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic is on the source record.

What is the OpenAlex record for Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic?

The OpenAlex for Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic is on the source record.